Harvard Researchers Develop Safe, On-Demand Living Therapeutics

David Mooney, seen in his lab, spearheaded a research team at Harvard’s Wyss Institute, focusing on on-demand living therapeutics. The new “Implantable Living Materials” (ILM) platform could revolutionize how microbial medicines are deployed in the future. As of May 14, 2026, this innovation suggests that patient recovery from severe conditions could improve by targeting drug…

Read More